Bristol-Myers Squibb
BMY
#169
Rank
NZ$230.76 B
Marketcap
NZ$112.97
Share price
0.35%
Change (1 day)
40.74%
Change (1 year)

EPS for Bristol-Myers Squibb (BMY)

EPS in 2026 (TTM): NZ$6.10

According to Bristol-Myers Squibb's latest financial reports the company's current EPS (TTM) is NZ$6.02. In 2025 the company made an earnings per share (EPS) of NZ$5.85 an increase over its 2024 EPS that were of NZ-$7.47.

EPS history for Bristol-Myers Squibb from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$6.104.35%
2025NZ$5.85-178.28%
2024NZ-$7.47-213.92%
2023NZ$6.5630.2%
2022NZ$5.04-6.04%
2021NZ$5.36-179.29%
2020NZ-$6.76-281.37%
2019NZ$3.73-27.21%
2018NZ$5.12
2016NZ$4.51175.26%
2015NZ$1.64-19.83%
2014NZ$2.05-22.44%
2013NZ$2.6434.48%
2012NZ$1.96

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$14.77 145.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$11.87 97.19%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.22-63.20%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$3.48-42.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$47.73 692.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$24.48 306.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$4.33-28.10%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
NZ$15.81 162.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$6.04 0.42%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$11.75 95.22%๐Ÿ‡ฌ๐Ÿ‡ง UK